Abstract
Narcolepsy is a severe, chronic, disabling disease affecting almost all personal and social activities. Sleep disorder specialists deal with the disabling burden of narcolepsy since their first approach to the patient. The disease continues to be a burden throughout the patient’s life as pharmacological and behavioral treatments only seldom control the variety of symptoms. Empirical data showed that from one fourth to half of people with narcolepsy are forced to modify or leave a job due to the disease, which may also cause higher absenteeism due to disability and accidents, as well as being more likely subjected to unemployment and early retirement with high social and economic costs. Excessive daytime sleepiness seems to be the main symptom associated with work disability, but cataplexy may be even more disabling in cases with many cataplectic attacks. Since people with narcolepsy experience a wide range of occupational problems, both clinicians and researchers are interested in how to help their patients to hold down a job, return to work, and, if necessary, receive benefits for work disability.
This chapter considers the medicolegal aspects of work disability in narcolepsy, summarizing essential issues clinicians and researchers have to address in providing medical information to assist disability determination in people with narcolepsy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Broughton R, Ghanem Q. The impact on compound narcolepsy in the life of the patient. In: Guilleminault C, Dement W, Passouant P, Weitzman E, editors. Narcolepsy. Holliswood, NY: Spectrum; 1976. p. 201–20.
Broughton R, Ghanem Q, Hishikawa Y, Sugita Y, Nevsimalova S, Roth B. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci. 1981;8(4):299–304.
Kales A, Soldatos CR, Bixler EO, Caldwell A, Cadieux RJ, Verrechio JM, Kales JD. Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology. Arch Neurol. 1982;39(3):169–71. doi:10.1001/archneur.1982.00510150039009.
Broughton R, Guberman A, Roberts J. Comparison of psychosocial effects of epilepsy and narcolepsy/cataplexy. Epilepsia. 1984;25(4):423–33. doi:10.1111/j.1528-1157.1984.tb03438.x.
Broughton R, Ghanem Q, Hishikawa Y, Sugita Y, Nevsimalova S, Roth B. Life effects of narcolepsy: relationships to geographic origin (North American, Asian or European) and to other patient and illness variables. Can J Neurol Sci. 1983;10(2):100–4.
Beusterien KM, Rogers AE, Walsleben JA, Emsellem HA, Reblando JA, Wang L, Goswami M, Steinwald B. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep. 1999;22(6):757–65.
Daniels E, King MA, Smith IE, Shneerson JM. Health-related quality of life in narcolepsy. J Sleep Res. 2001;10(1):75–81. doi:10.1046/j.1365-2869.2001.00234.x.
Teixeira VG, Faccenda JF, Douglas NJ. Functional status in patients with narcolepsy. Sleep Med. 2004;5(5):477–83. doi:10.1016/j.sleep.2004.07.001.
Vignatelli L, D’Alessandro R, Mosconi P, Ferini-Strambi L, Guidolin L, De Vincentiis A, Plazzi G. Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. Sleep Med. 2004;5(5):467–75. doi:10.1016/j.sleep.2004.04.003.
Vignatelli L, Plazzi G, Peschechera F, Delaj L, D’Alessandro R. A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. Sleep Med. 2011;12(1):19–23. doi:10.1016/j.sleep.2010.07.008.
Ervik S, Abdelnoor M, Heier MS, Ramberg M, Strand G. Health-related quality of life in narcolepsy. Acta Neurol Scand. 2006;114(3):198–204. doi:10.1111/j.1600-0404.2006.00594.x.
Dodel R, Peter H, Spottke A, Noelker C, Althaus A, Siebert U, Walbert T, Kesper K, Becker HF, Mayer G. Health-related quality of life in patients with narcolepsy. Sleep Med. 2007;8(7):733–41. doi:10.1016/j.sleep.2006.10.010.
Campbell AJ, Signal TL, O’Keeffe KM, Bakker JP. Narcolepsy in New Zealand: pathway to diagnosis and effect on quality of life. J N Z Med Assoc. 2011;124(1336):51–61.
David A, Constantino F, dos Santos JM, Paiva T. Health-related quality of life in Portuguese patients with narcolepsy. Sleep Med. 2012;13(3):273–7. doi:10.1016/j.sleep.2011.06.021.
Ozaki A, Inoue Y, Hayashida K, Nakajima T, Honda M, Usui A, Komada Y, Kobayashi M, Takahashi K. Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naïve patients and the general Japanese population. Sleep Med. 2012;13(2):200–6. doi:10.1016/j.sleep.2011.07.014.
Morrish E, King MA, Smith IE, Shneerson JM. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med. 2004;5(1):37–41. doi:10.1016/j.sleep.2003.06.002.
Thorpy MJ, Krieger AC. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med. 2014;15(5):502–7. doi:10.1016/j.sleep.2014.01.015.
Groce N. Cultural beliefs and practices influence the type and nature of data collected on individuals with disability through national census. In: Altman BM, Barnartt SN, editors. International views on disability measures: moving toward comparative measurement. Amsterdam: Elsevier; 2006. p. 41–54.
World Health Organization. International classification of impairments, disabilities, and handicaps: a manual of classification relating to the consequences of disease. Geneva: World Health Organization; 1980.
World Health Organization. International classification of functioning, disability and health: ICF. Geneva: World Health Organization; 2001.
World Health Organization. Towards a common language for functioning, disability and health: ICF. 2002. http://www3.who.int/icf/beginners/bg.pdf. Accessed 21 Dec 2014.
Gradinger F, Cieza A, Stucki A, Michel F, Bentley A, Oksenberg A, Rogers AE, Stucki G, Partinen M. Part 1. International classification of functioning, disability and health (ICF) core sets for persons with sleep disorders: results of the consensus process integrating evidence from preparatory studies. Sleep Med. 2011;12(1):92–6. doi:10.1016/j.sleep.2010.08.009.
Stucki A, Cieza A, Michel F, Stucki G, Bentley A, Culebras A, Tufik S, Kotchabhakdi N, Tachibana N, Ustun B, Partinen M. Developing ICF core sets for persons with sleep disorders based on the international classification of functioning, disability and health. Sleep Med. 2008;9(2):191–8. doi:10.1016/j.sleep.2007.01.019.
Gradinger F, Köhler B, Khatami R, Mathis J, Cieza A, Bassetti C. Problems in functioning from the patient perspective using the international classification of functioning, disability and health (ICF) as a reference. J Sleep Res. 2011;20(1pt2):171–82. doi:10.1111/j.1365-2869.2010.00862.x.
Gradinger F, Glässel A, Gugger M, Cieza A, Braun N, Khatami R, Schmitt W, Mathis J. Identification of problems in functioning of people with sleep disorders in a clinical setting using the international classification of functioning disability and health (ICF) checklist. J Sleep Res. 2011;20(3):445–53. doi:10.1111/j.1365-2869.2010.00888.x.
Rondinelli RD, editor. Guides to the evaluation of permanent impairment. 6th ed. Chicago, IL: AMA; 2008.
de Jong PR. Disability and disability insurance. In: Prinz C, editor. European disability pension policies. Aldershot: Ashgate; 2003. p. 77–106.
Alaia SL. Life effects of narcolepsy: measures of negative impact, social support, and psychological well- being. In: Goswami M, Pollack CP, Cohen FL, Thorpy MJ, Kavey NB, Kutscher AH, editors. Psychosocial aspects of narcolepsy. New York: Haworth; 1992. p. 1–22.
Ferrans CE, Cohen FL, Smith KM. The quality of life of persons with narcolepsy. In: Goswami M, Pollack CP, Cohen FL, Thorpy MJ, Kavey NB, Kutscher AH, editors. Psychosocial aspects of narcolepsy. New York: Haworth; 1992. p. 23–32.
Ingravallo F, Gnucci V, Pizza F, Vignatelli L, Govi A, Dormi A, Pelotti S, Cicognani A, Dauvilliers Y, Plazzi G. The burden of narcolepsy with cataplexy: how disease history and clinical features influence socio-economic outcomes. Sleep Med. 2012;13(10):1293–300. doi:10.1016/j.sleep.2012.08.002.
Frauscher B, Ehrmann L, Mitterling T, Gabelia D, Gschliesser V, Brandauer E, Poewe W, Högl B. Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the Innsbruck narcolepsy cohort. J Clin Sleep Med. 2013;9(8):805. doi:10.5664/jcsm.2926.
Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology. 1998;50(2 Suppl 1):S31–6. doi:10.1212/WNL.50.2_Suppl_1.S31.
Dodel R, Peter H, Walbert T, Spottke A, Noelker C, Berger K, Siebert U, Oertel WH, Kesper K, Becker HF, Mayer G. The socioeconomic impact of narcolepsy. Sleep. 2004;27(6):1123–8.
Jennum P, Knudsen S, Kjellberg J. The economic consequences of narcolepsy. J Clin Sleep Med. 2009;5(3):240–5.
Jennum P, Ibsen R, Petersen ER, Knudsen S, Kjellberg J. Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners. Sleep Med. 2012;13(8):1086–93. doi:10.1016/j.sleep.2012.06.006.
Black J, Reaven NL, Funk SE, McGaughey K, Ohayon M, Guilleminault C, Ruoff C, Mignot E. The burden of narcolepsy disease (BOND) study: health-care utilization and cost findings. Sleep Med. 2014;15(5):522–9. doi:10.1016/j.sleep.2014.02.001.
Guilleminault C. Narcolepsy. In: Chokroverty S, editor. Sleep disorders medicine: basic science, technical considerations, and clinical aspects. Boston: Butterworth-Heinemann; 1994. p. 241–54.
Goswami M, Thorpy MJ. Commentary on the article by Ingravallo et al. “The burden of narcolepsy with cataplexy: how disease history and clinical features influence socio-economic outcomes”. Sleep Med. 2012;14(4):301–2. doi:10.1016/j.sleep.2012.11.018.
Dement WC. Daytime sleepiness and sleep “attacks”. In: Guilleminault C, Dement W, Passouant P, Weitzman E, editors. Narcolepsy. Holliswood, NY: Spectrum; 1976. p. 17–34.
Overeem S, van Nues SJ, van der Zande WL, Donjacour CE, van Mierlo P, Lammers GJ. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med. 2011;12(1):12–8. doi:10.1016/j.sleep.2010.05.010.
Ingravallo F, Vignatelli L, Brini M, Brugaletta C, Franceschini C, Lugaresi F, Manca MC, Garbarino S, Montagna P, Cicognani A, Plazzi G. Medico- legal assessment of disability in narcolepsy: an interobserver reliability study. J Sleep Res. 2008;17(1):111–9. doi:10.1111/j.1365-2869.2008.00630.x.
George CFP, Boudreau AC, Smiley A. Comparison of simulated driving performance in narcolepsy patients. Sleep. 1996;19(9):711–7.
Kotterba S, Mueller N, Leidag M, Widdig W, Rasche K, Malin JP, Schultze-Werninghaus G, Orth M. Comparison of driving simulator performance and neuropsychological testing in narcolepsy. Clin Neurol Neurosurg. 2004;106(4):275–9. doi:10.1016/j.clineuro.2003.12.003.
Guilleminault C, Abad VC. Narcolepsy. In: Chokroverty S, editor. Sleep disorders medicine. Basic science, technical considerations and clinical aspects. Philadelphia: Saunders; 2009. p. 319–39.
Mayer G, Pollmacher T, Meier-Ewert K, Schulz H. Assessment of the degree of disability in narcolepsy. Gesundheitswesen. 1993;55(7):337–42.
Mayer G. Aspects of medical expert assessment of sleep-waking disorders. Wien Med Wochenschr. 1996;146(13–14):391–5.
Rühle KH, Mayer G. Recommendations and expert aspects for the judgement on sleep wake disorders and excessive daytime sleepiness. Somnologie. 1998;2:89–95.
Ingravallo F, Plazzi G. Medico-legal aspects of disability in narcolepsy. In: Goswami M, Pandi-Perumal SR, Thorpy MJ, editors. Narcolepsy. A clinical guide. New York: Springer; 2010. p. 231–7.
American Academy of Sleep Medicine. International classification of sleep disorders, revised: diagnostic and coding manual. Chicago, IL: American Academy of Sleep Medicine; 2001.
American Academy of Sleep Medicine. International classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology. 2002;58(12):1826–33. doi: 10.1212/WNL.58.12.1826.
American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, Lee-Chiong T, Hirshkowitz M, Loube DL, Bailey D, Berry RB, Kapen S, Kramer M. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 2005;28(1):113–21.
Stattin M. Retirement on grounds of ill health. Occup Environ Med. 2005;62(2):135–40. doi:10.1136/oem.2004.015669.
OECD. Transforming disability into ability. Policies to promote work and income security for disabled people. Paris: OECD; 2003.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ingravallo, F., Plazzi, G. (2016). Medicolegal Aspects of Disability in Narcolepsy. In: Goswami, M., Thorpy, M., Pandi-Perumal, S. (eds) Narcolepsy. Springer, Cham. https://doi.org/10.1007/978-3-319-23739-8_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-23739-8_30
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23738-1
Online ISBN: 978-3-319-23739-8
eBook Packages: MedicineMedicine (R0)